|
Market Closed -
Nasdaq
16:00:00 2024-12-23 EST
|
5-day change | 1st Jan Change | ||
| 0.2531 USD | +4.20% |
|
-.--% | - |
| 09-18 | Neuphoria Therapeutics Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 07-23 | Scancell Holdings plc agreed to acquire Neuphoria Therapeutics Inc. for $35 million. | CI |
Stock exchange
Performance
| 1 day | +4.20% | ||
| 3 years | -93.58% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
18,993,782
Net sales (AUD)
1,651,700
Net sales (USD)
1,147,971
Number of employees
1
Sales / Employee (AUD)
1,651,700
Sales / Employee (USD)
1,147,971
Free-Float
94.98%
Free-Float capitalization (USD)
18,040,533
Indicators
Moving average 5 days
0.2562
Moving average 100 days
0.4244
Price spread / (MMA5)
+1.22%
Price spread / (MMA100)
+67.68%
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.20% | -.--% | -.--% | -93.58% | 18.99M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.41B | |
| -3.11% | -3.53% | +21.92% | +74.60% | 59.26B | |
| +0.89% | -0.63% | +4.28% | +34.51% | 47.14B | |
| -0.96% | -4.50% | +26.36% | +33.18% | 42.91B | |
| +0.36% | +0.81% | +352.17% | +689.61% | 44.13B | |
| -0.20% | -0.77% | +3.74% | +100.60% | 40.79B | |
| -0.54% | +2.93% | +9.31% | +50.41% | 30.77B | |
| -2.68% | +2.92% | +29.63% | +19.50% | 29.31B | |
| +2.33% | -5.69% | -27.28% | +338.00% | 23.71B | |
| Average | +0.44% | -0.79% | +46.95% | +134.10% | 39.25B | |
| Weighted average by Cap. | +0.24% | -0.98% | +57.35% | +150.72% |
Historical Quotes: BIONOMICSSADR
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 0.18 |  | 4.8 |
| 5 years | 0.18 | | 22 |
| 10 years | 0.18 | | 22 |
Monthly variations
Annual variations
| 2024 | -82.90% | ||
| 2023 | -68.17% | ||
| 2022 | -62.95% | ||
| 2021 | -14.80% |
- Stock Market
- Stocks
- NEUP Stock
- BNOX Stock
- Quotes BIONOMICSSADR
Select your edition
All financial news and data tailored to specific country editions
